Arrowhead Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Arrowhead Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Arrowhead Pharmaceuticals Inc.
Rating: 2.114111
Author: Trendlyne DVM scores

Expensive Rocket

about

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed a...

64.56 -0.44 (-0.68%)

New 52W High in past week

2.4M

XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Arrowhead Pharma Inc is on 12 Jan 2026 for the purpose of J.P. Morgan 2026 Healthcare Conference See details

Medium Financial Strength

44.4 / 100

Expensive Valuation

11.5 / 100

Technically Moderately Bullish

68.7 / 100

Expensive Rocket These stocks have good momentum, but are expensive with average financials View Similar Embed DVM

1Yr Price target upside is 21%

11 analysts

Arrowhead Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arrowhead Pharma Inc Live Stock Price Today, Share Analysis and Chart

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed a...

New 52W High in past week

SWOT Analysis

Arrowhead Pharma Inc Live Price Chart